Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hans Peter Brezinschek
A Combination of Cellular Biomarkers Predicts Failure to Respond to Rituximab in Rheumatoid Arthritis: A 24-Week Observational Study
Arthritis Research & Therapy
Related publications
Safety of Rituximab in Rheumatoid Arthritis
Reumatismo
Rheumatology
IgG Fc Galactosylation Predicts Response to Methotrexate in Early Rheumatoid Arthritis
Arthritis Research & Therapy
B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study
PLoS ONE
Multidisciplinary
A Systems Approach to Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
Step-Up Combination Versus Switching of Non-Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results From a Retrospective Observational Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Rituximab Therapy in Greek Patients With Rheumatoid Arthritis
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
To: A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease
Neurology
Neurology
Rituximab Treatment in a Patient With Primary Biliary Cirrhosis and Rheumatoid Arthritis
Archives of Rheumatology
Rheumatology